BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shah J, Shah A, Hassman L, Gutierrez A. Ocular Manifestations of Inflammatory Bowel Disease. Inflamm Bowel Dis 2021:izaa359. [PMID: 33501989 DOI: 10.1093/ibd/izaa359] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Rakowsky S, Papamichael K, Cheifetz AS. Choosing the right biologic for complications of inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology. [DOI: 10.1080/17474124.2022.2036122] [Reference Citation Analysis]
2 Takeuchi M, Mizuki N, Ohno S. Pathogenesis of Non-Infectious Uveitis Elucidated by Recent Genetic Findings. Front Immunol 2021;12:640473. [PMID: 33912164 DOI: 10.3389/fimmu.2021.640473] [Reference Citation Analysis]
3 Sandhu S, Wang T, Donet JA. Orbital Myositis in a Patient With Ileal Crohn's Disease in Remission on Vedolizumab. ACG Case Rep J 2022;9:e00775. [DOI: 10.14309/crj.0000000000000775] [Reference Citation Analysis]
4 Li P, Zhang HY, Gao JZ, Du WQ, Tang D, Wang W, Wang LH. Mesenchymal stem cells-derived extracellular vesicles containing miR-378a-3p inhibit the occurrence of inflammatory bowel disease by targeting GATA2. J Cell Mol Med 2022. [PMID: 35582765 DOI: 10.1111/jcmm.17176] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]